342
Over 350 patients, medical professionals, representatives of pharmaceutical companies participated in the First National Conference for Rare Diseases and Orphan Drugs, part of EUROPLAN project, funded by the European Commission. Proposals, made during event, were summarized and adopted in a memorandum, which you can find here. Additional information from the official media partner of the conference – ZDRAVE.net – you can read here.